Cable Hill Partners, LLC Gsk PLC Transaction History

Cable Hill Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$42.05 - $47.77 $300,110 - $340,934	7,137 New	7,137 $311,000
Q2 2019 Aug 06, 2019	SELL	$39.4 - $42.7 $87,507 - $94,836	-2,221 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$38.57 - $42.69 $3,471 - $3,842	-90 Reduced 3.89%	2,221 $93,000
Q4 2018 Feb 12, 2019	BUY	$37.8 - $42.69 $79,380 - $89,649	2,100 Added 995.26%	2,311 $88,000
Q4 2017 Feb 22, 2018	SELL	$35.34 - $41.9 $187,549 - $222,363	-5,307 Reduced 96.18%	211 $8,000
Q3 2017 Oct 27, 2017	BUY	$39.44 - $41.55 $213,685 - $225,117	5,418 Added 5418.0%	5,518 $224,000
Q2 2017 Aug 14, 2017	BUY	N/A	100	100 $4,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.